Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Coya Therapeutics Inc (COYA)

  • Business News
  • Nov. 12, 2025, 13:02 UTC
  • 12
  • 0 comments

CoyaTherapeutics - Coya Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update

Market reaction Comment Full text

Allurion Technologies Inc (ALUR)

  • Business News
  • Nov. 12, 2025, 13:02 UTC
  • 9
  • 0 comments

Allurion - Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

Market reaction Comment Full text

Corbus Pharmaceuticals Holdings Inc. (CRBP)

  • Business News
  • Nov. 12, 2025, 13:02 UTC
  • 10
  • 0 comments

Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Market reaction Comment Full text

Agilent Technologies Inc. (A)

  • Business News
  • Nov. 12, 2025, 13:01 UTC
  • 10
  • 0 comments

Agilent Technologies, Inc. - Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics

Market reaction Comment Full text

Natera Inc (NTRA)

  • Business News
  • Nov. 12, 2025, 13:01 UTC
  • 9
  • 0 comments

Natera - Natera Integrates with FlatironHealth’s OncoEMR® Platform

Market reaction Comment Full text

Sensus Healthcare Inc (SRTS)

  • Business News
  • Nov. 12, 2025, 13:01 UTC
  • 13
  • 0 comments

Sensus Healthcare Appoints Eric Sachetta to its Board of Directors

Market reaction Comment Full text

Mainz Biomed (MYNZ)

  • Business News
  • Nov. 12, 2025, 13:01 UTC
  • 22
  • 1 comments

Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025

Market reaction Comment Full text

BullFrog AI Holdings Inc Unit (BFRG)

  • Business News
  • Nov. 12, 2025, 13:00 UTC
  • 12
  • 0 comments

BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025

Market reaction Comment Full text

Reviva Pharmaceuticals Holdings Inc. (RVPH)

  • Business News
  • Nov. 12, 2025, 13:00 UTC
  • 9
  • 0 comments

Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

Market reaction Comment Full text

Collegium Pharmaceutical Inc (COLL)

  • Business News
  • Nov. 12, 2025, 13:00 UTC
  • 20
  • 1 comments

Collegium to Participate in Upcoming Investor Conferences

Market reaction Comment Full text
  • Previous
  • 695
  • 696
  • 697
  • 698
  • 699
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2435)
  • SEC News(193311)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125842)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin